诊断前列腺癌:膀胱内前列腺突出对前列腺穿刺活检准确性的作用
研究评估了膀胱内前列腺突出(IPP)与磁共振-经直肠超声融合靶向活检(TB)检出临床显著前列腺癌(csPCa)的关系。共538例连续男性接受融合靶向活检及系统活检,结果显示IPP每增加1 mm,TB检出csPCa的比值降低5.6%(p=0.004),大IPP较0 IPP检出比值降低66.5%(p=0.003)。
要点
- IPP每增加1 mm,靶向活检检出csPCa的比值降低5.6%(p=0.004)。
- 大IPP较0 IPP检出csPCa的比值降低66.5%(p=0.003)。
- IPP总大小与csPCa检出的总体关系不显著,但大IPP与0 IPP间差异显著(p=0.007)。
核心结论
- 随着IPP尺寸和体积增大,MRI引导靶向活检检出csPCa的检出率降低;作者认为这些发现可能由MRI-TRUS配准不良和前列腺不对称驱动。
研究设计与样本
- 共评估538例连续接受MRI-TRUS融合靶向活检并同期系统活检的男性;IPP由4名盲法评估者独立在MRI上测量;主要结局为靶向活检每病灶检出csPCa。
主要发现
- 共对847个PI-RADS 3分及以上病灶进行靶向活检,分布在570次活检中;IPP测量组内和组间信度强。
- 81例(14.2%)、127例(22.3%)、237例(41.6%)和125例(21.9%)男性分别为0、小、中和大IPP。
- 病灶PI-RADS 3、4、5分分别为230、392和196个;198个病灶(34.7%)靶向活检检出csPCa。
- IPP大小与靶向活检检出csPCa的总体关系不显著;大IPP较0 IPP的csPCa检出率显著更低(p=0.007)。
- IPP每增加1 mm,靶向活检检出csPCa的比值降低5.6%(p=0.004);大IPP较0 IPP检出比值降低66.5%(p=0.003)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the association between intravesical prostate protrusion (IPP) and the detection rate of clinically significant prostate cancer (csPCa) on magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion targeted biopsy (TB). MATERIALS AND METHODS: A total of 538 consecutive men who underwent MRI-TRUS fusion TB and concomitant systematic biopsy were evaluated. IPP on MRI was independently measured by 4 blinded reviewers. The primary outcome was per-lesion detection of csPCa on TB. We assessed the association between IPP and csPCa detection on TB, controlling for age, prostate specific antigen, Prostate Imaging Reporting and Data System® (PI-RADS®) score, prostate volume, targeted cores sampled and previous biopsy experience. RESULTS: A total of 847 PI-RADS 3 or greater lesions were targeted across 570 biopsies. Intra- and interrater reliability for measuring IPP was strong. A total of 81 (14.2%), 127 (22.3%), 237 (41.6%) and 125 (21.9%) men had 0, small, medium and large IPP, respectively. A total of 230, 392 and 196 lesions were PI-RADS 3, 4 and 5, respectively. Of the lesions 198 (34.7%) had csPCa on TB. The overall relationship between IPP size and csPCa found on TB was not significant; however, large IPP is associated with a significantly lower rate of csPCa detection than 0 IPP (p=0.007). Every mm increase in IPP is associated with a 5.6% decrease in the odds of csPCa detection on TB (p=0.004) and a 66.5% decrease in odds of detection in large IPP compared to 0 IPP (p=0.003). CONCLUSIONS: As the size of the IPP and volume increase, there is a decrease in the detection rate of csPCa on MRI-guided TB. These findings may be driven by poor MRI-TRUS co-registration and prostate asymmetry.
引用
- Rosenberg JE, Jarosek S, Spilseth B, et al. Diagnosing Prostate Cancer: The Role of Intravesical Prostatic Gland Protrusion on Accuracy of Prostate Biopsies. J Urol. 2022. PMID: 35080472. doi:10.1097/JU.0000000000002448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。